oncogenic targets

Boehringer Ingelheim Collaborates with Proxygen to Explore Molecular Glue Degraders – a Novel Approach to Fight Cancer

Vienna, Austria & Ingelheim, Germany:  – New collaboration strengthens Boehringer Ingelheim’s cancer research strategy to develop novel treatment options for…

Read More »